A glutamine metabolish-associated prognostic model to predict prognosis and therapeutic responses of hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) ranks among the most lethal malignancies around the world. However, the current management strategies for predicting prognosis in HCC patients remain unreliable. Our study developed a robust prognostic model based on glutamine metabolism associated-genes (GMAG...
Saved in:
| Main Authors: | Hao Xu, Hui Pan, Lian Fang, Cangyuan Zhang, Chen Xiong, Weiti Cai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-11-01
|
| Series: | Biology Direct |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13062-024-00567-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of prognostic nutrition index in the prognosis of patients with advanced hepatocellular carcinoma who received first-line therapy
by: Jianwei Liu, et al.
Published: (2025-08-01) -
Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma
by: Benjian Gao, et al.
Published: (2025-10-01) -
Targeting RECQL4 in hepatocellular carcinoma: from prognosis to therapeutic potential
by: Yingchen Li, et al.
Published: (2025-02-01) -
Mechanisms of HRAS regulation of liver hepatocellular carcinoma for prognosis prediction
by: Xingbao Fang, et al.
Published: (2025-04-01) -
New prognostic model for liver transplantation outcomes in hepatocellular carcinoma
by: S. E. Voskanyan, et al.
Published: (2024-09-01)